Список литературы

1. Kohler S., Kerl H. Neural tumors. WHO Classification of tumours. 2006; N 6: с. 272.

2. Lanoy E., Costagliola D., Engels E.A. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 2010; 126(7): 1724 - 31.

3. Lanoy E., Dores G.M., Madeleine M.M., Toro J.R., Fraumeni J.F., Jr., Engels E.A. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS 2009; 23(3): 385 - 93.

4. Koljonen V., Kukko H., Tukiainen E., Bohling T., Sankila R., Pukkala E., et al. Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 2009; 24(10): 3231 - 5.

5. Lunder E.J., Stern R.S. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med. 1998; 339: с. 1247 - 1248.

6. Popp S., Waltering S., Herbst C., Moll I. Boukamp P.Uv-b-type mutations and chromosomal imbalances indicate common pathways for the development of merkel and skin squamous cell carcinomas. Int. J. Cancer. 2002; 99: с. 352 - 360.

7. Feng H., Shuda M., Chang Y., Moore P. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Sience. 2008; 319: с. 1096 - 1100.

8. Киселев, Ф.Л., Имянитов Е.Н., Киселева Н.П., Левина Е.С. Молекулярная онкология: от вирусной теории к лечению рака. М.: ГЕОС. 2013: с. 38 - 40.

9. Rollison D.E., Giuliano A.R., Becker J.C. New virus associated with merkel cell carcinoma development. J Natl Compr Canc Netw. 2010; 8: 874 - 880.

10. Amber K, McLeod MP, Nouri K. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg. 2013; 39: 232 - 238.

11. Schwartz R.A. Skin Cancer. Recognition and Management. Book 2d ed. 2008; N 13: с. 220 - 225.

12. IMMOMEC (European Commission). Merkel cell carcinoma. Available at: http: //www.immomec.eu/project/objectives/background/merkel-cell-carcinoma/Last accessed April 2015

13. Edge S., Byrd D. et al. Merkel cell carcinoma. AJCC Cancer Staging Manual. Seventh Edition, 2010: с. 315 - 323.

14. Sobin L., Gospodarowicz M., Wittekind C. Merkel cell carcinoma. TNM Classification of Malignant Tumours. 7th Edition.

15. Heath M., Jaimes N., Lemos B. et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the "AEIOU" features. J Am Acad Dermatol. 2008; N 58: с. 375 - 381.

16. Орлова К.В., Изучение клинико-морфологических и молекулярно-биологических аспектов карциномы Меркеля. Диссер. на соискание уч. степ. кан.мед.наук. 2015: с. 49 - 51.

17. Rao P., Balzer B.L., Lemos B.D. et al. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med. 2010; 134: 341 - 344.

18. Andea A.A., Coit D.G., Amin B., Busam K.J. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113: 2549 - 2558.

19. Scott M.P., Helm K.F. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 1999; 21: 16 - 20.

20. Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000; 27: 118 - 120.

21. M., Wasr B., Schonbrunn A., Perren A., Reubi J.C. Somatostatin receptor subtype 2a immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting. Am. J. Surg. Pathol. 2012; 36(2): с. 242 - 52.

22. Buder K., Lapa C., Kreissl M.C., Schirbel A., Herrmann K., Schnack A., E.B., Goebeler M., Buck A.K., Becker J.C. Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging. BMC Cancer. 2014; (14): 268.

23. Reisine T., Bell G. Molecular biology of somatostatin receptors. Endocr Rev. 1995; (16): с. 427 - 442.

24. Bichakjian C.K., Lowe L., Lao C.D. et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007; 110: 1 - 12.

25. Becker J.C. Merkel cell carcinoma. Ann Oncol. 2010; 21 Suppl 7: vii81 - vii85.

26. Schneider S., Thurnher D., Erovic B.M. Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer 2013; 2013: 189342.

27. Siva S., Byrne K., Seel M. et al. 18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in the Staging of Merkel Cell Carcinoma: A 15-Year Institutional Experience. J Nucl Med 2013.

28. Hawryluk E.B., O"Regan K.N., Sheehy N., et al. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women"s Cancer Center. J Am Acad Dermatol 2013; 68: 592 - 599.

29. Treglia G., Dabbagh Kakhki V.R., Giovanella L., Sadeghi R. Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis. Am J Clin Dermatol 2013.

30. Schmalbach C.E., Lowe L., Teknos T.N., et al. Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg. 2005; 131: 610 - 614.

31. Gupta S.G., Wang L.C., Penas P.F., et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol. 2006; 142: 685 - 690.

32. Allen P.J., Busam K., Hill A.D., et al. Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer 2001; 92: 1650 - 1655.

33. Su L.D., Lowe L., Bradford C.R., et al. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol. 2002; 46: 661 - 666.

34. Bichakjian C.K. et al. Merkel cell carcinoma. NCCN Clinical practice guidelines in oncology. 2017; (1).

35. llen P.J., Zhang Z.F., Coit D.G. Surgical management of Merkel cell carcinoma. Ann Surg. 1999; 229: 97 - 105.

36. Santamaria-Barria J.A., Boland G.M., Yeap B.Y., et al. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol. 2013; 20: 1365 - 1373.

37. Schneider S., Thurnher D., Erovic B.M. Merkel cell carcinoma: interdisciplinary management of a rare disease. J Skin Cancer 2013; 2013: 189342.

38. Tai P. A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg 2013; 2013: 850797.

39. Kim J.A., Choi A.H. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis. JAMA Dermatol. 2013; 149: 831 - 838.

40. Mojica P., Smith D., Ellenhorn J.D. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007; 25: 1043 - 1047.

41. Rush Z., Fields R.C., Lee N., Brownell I. Radiation therapy in the management of Merkel cell carcinoma: current perspectives. Expert Rev Dermatol. 2011; 6: 395 - 404.

42. Lewis K.G., Weinstock M.A., Weaver A.L., Otley C.C. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006; 142: 693 - 700.

43. Jouary T., Leyral C., Dreno B., et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2012; 23: 1074 - 1080.

44. Voog E., Biron P., Martin J.P., Blay J.Y. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer. 1999; 85: 2589 - 2595.

45. Tai P.T., Yu E., Winquist E., et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000; 18: 2493 - 2499.

46. Pectasides D., Pectasides M., Psyrri A., et al. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin. Cancer Invest. 2006; 24: 780 - 785.

47. Desch L., Kunstfeld R. Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer. 2013; 2013: 327150.

48. L., P., Rinke A. Antitumor effects of somatostatin analogs in neuroendocrine tumors. Oncologist. 2012; 17(6): с. 747 - 55.

49. Strosberg J., Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J. Gastroenterol. 2010; 16(24): с. 2963 - 70.

50. C. Susini L. Buscail. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006; 17(12): с. 1733 - 1742.

51. Di Bartolomeo M., Bajetta E., Buzzoni R. et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer. 1996; (77): с. 402 - 408.

52. Fakiha M., Letertre P., Vuillez J.P., Lebeau J. Remission of Merkel cell tumor after somatostatin analog treatment. J Cancer Res Ther. 2010; 6(3): с. 382 - 384.

53. Nghiem P.T., Shailender B., Lipson E.J. et al. PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma. N Engl J Med. 2016; 19 Apr: 1 - 16. DOI: 10.1056/NEJMoa1603702.

54. Garneski K.M., Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol. 2007; 57: 166 - 169.

55. Poulsen M.G., Rischin D., Porter I., et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006; 64: 114 - 119.

56. Albores-Saavedra J., Batich K., Chable-Montero F. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010; 37(1): 20 - 7.

57. DeMay R.M. Merkel cell carcinoma. The art and science of cytopathology, 2^nd edition. 2012; 717.